Skip to main content

Table 1 Patient characteristics and perioperative data

From: Non-pulsatile blood flow is associated with enhanced cerebrovascular carbon dioxide reactivity and an attenuated relationship between cerebral blood flow and regional brain oxygenation

Gender male/female ratio n (%)23/8 (74/26)
Age (years) mean ± SD65 ± 8
Arterial hypertension n (%)23 (74)
Chronic obstructive lung disease n (%)4 (12)
Diabetes n (%)5 (16)
Current smoker n (%)10 (32)
Left ventricular ejection fraction n (%)
 > 50%21 (67)
 40–50%4 (12)
 < 40%7 (22)
Height (cm) mean ± SD172 ± 9
Bodyweight (kg) mean ± SD82 ± 16
Body mass index (kg/m2) mean ± SD28 ± 5
No antiplatelet therapy n (%)16 (51)
Single antiplatelet therapy n (%)11 (35)
Dual antiplatelet therapy n (%)5 (16)
Surgical procedure n (%)
 CABG only10 (32)
 CABG with aortic valve replacement/repair7 (22)
 CABG with mitral valve replacement/repair7 (22)
 Aortic valve replacement7 (22)
Vasoactive agents
 Dobutamine n (%)11 (35)
 Noradrenaline n (%)31 (100)
 Levosimendan n (%)5 (16)
Blood and coagulation products
 Packed red blood cells n (%)13 (41)
 Fibrinogen n (%)11 (35)
 Tranexamic acid n (%)31 (100)
 Tranexamic acid (g) mean ± SD2.5 ± 1.0
 Cardiopulmonary bypass time (min) mean ± SD148 ± 75
 Aortic cross-clamping time (min) mean ± SD93 ± 48
 Mild hypothermia n (%)9 (29)
 Highest serum lactate level (mg/dL) mean ± SD2.7 ± 2
  1. SD standard deviation, n number of patients, CABG coronary artery bypass graft
  2. Data are either presented as absolute numbers (percentage) or as means ± SD